Document is current
Any future updates will be listed below
-
Authors
Ohama, Hideko https://orcid.org/0000-0002-1882-824X
Hiraoka, Atsushi https://orcid.org/0000-0003-1989-0480
Tada, Toshifumi https://orcid.org/0000-0002-0976-6761
Hirooka, Masashi https://orcid.org/0000-0001-5634-5313
Kariyama, Kazuya https://orcid.org/0000-0003-3996-7502
Tani, Joji https://orcid.org/0000-0001-8801-2505
Atsukawa, Masanori
Takaguchi, Koichi https://orcid.org/0000-0003-0175-8721
Itobayashi, Ei https://orcid.org/0000-0003-0475-2819
Fukunishi, Shinya
Tsuji, Kunihiko https://orcid.org/0009-0007-4152-9364
Ishikawa, Toru https://orcid.org/0000-0002-5470-9694
Tajiri, Kazuto https://orcid.org/0000-0002-2373-8601
Tanaka, Hironori https://orcid.org/0000-0001-7795-3844
Toyoda, Hidenori https://orcid.org/0000-0002-1652-6168
Ogawa, Chikara https://orcid.org/0000-0002-4534-6692
Nishimura, Takashi https://orcid.org/0000-0002-5517-8303
Hatanaka, Takeshi https://orcid.org/0000-0003-3656-285X
Kakizaki, Satoru https://orcid.org/0000-0003-0224-7093
Kawata, Kazuhito https://orcid.org/0000-0002-4986-8578
Naganuma, Atsushi https://orcid.org/0000-0003-0663-0102
Kosaka, Hisashi https://orcid.org/0000-0002-2926-9973
Matono, Tomomitsu
Kuroda, Hidekatsu https://orcid.org/0000-0002-1471-1087
Yata, Yutaka
Nishikawa, Hiroki
Imai, Michitaka
Aoki, Tomoko https://orcid.org/0000-0002-9950-4553
Ochi, Hironori
Tamai, Hideyuki https://orcid.org/0000-0003-4511-4573
Komatsu, Shohei
Tada, Fujimasa https://orcid.org/0009-0007-3964-5876
Nakamura, Shinichiro https://orcid.org/0009-0001-5065-9669
Nakamura, Yoshiko
Miyake, Teruki
Yoshida, Osamu
Nouso, Kazuhiro https://orcid.org/0000-0002-2018-0008
Morishita, Asahiro https://orcid.org/0000-0002-0760-3045
Itokawa, Norio
Okubo, Tomomi
Arai, Taeang
Tsutsui, Akemi https://orcid.org/0000-0003-2978-2723
Nagano, Takuya
Tanaka, Kazunari https://orcid.org/0000-0001-9811-2665
Matsuura, Takanori https://orcid.org/0009-0008-7361-881X
Koshiyama, Yuichi
Kanayama, Yuki https://orcid.org/0000-0002-8639-5212
Noritake, Hidenao
Enomoto, Hirayuki
Matsui, Kosuke
Kaibori, Masaki https://orcid.org/0000-0002-0577-3921
Fukumoto, Takumi
Hiasa, Yoichi https://orcid.org/0000-0003-4117-339X
Kudo, Masatoshi https://orcid.org/0000-0002-4102-3474
Kumada, Takashi https://orcid.org/0000-0003-2211-495X
,
- License Information
-
More Information
Article History
Received: 28 May 2025
Accepted: 5 August 2025
First Online: 20 August 2025
Declarations
:
: Atsushi Hiraoka, MD, PhD: lecture fees from Eli Lilly, AstraZeneca, and Chugai. Toshifumi Tada, MD, PhD: lecture fees from AstraZeneca, AbbVie, Eisai, and Chugai. Satoru Kakizaki, MD, PhD: lecture fees from AbbVie. Kazuhito Kawata, MD, PhD: honoraria from AbbVie. Hidenori Toyoda, MD, PhD: lecture fees from AstraZeneca, KOWA, Bayer, Eisai, Chugai, Takeda, Terumo, AbbVie, Gilead, Fujifilm WAKO, and Abott. Hidekatsu Kuroda, MD, PhD: lecture fees from Eisai. Shohei Komatsu, MD, PhD: lecture fees from Chugai. Kazuhiro Nouso, MD, PhD: lecture fees from AbbVie, Aska Pharmaceutical, AstraZeneca, Bayer, Century Medical, Chugai, Covidien, Eisai, Gilead, Kowa, Lilly, FujiFilm, and Otsuka; and research funding from CureApp, Denka, Fuji film, and Medtronic. Yoichi Hiasa, MD, PhD: research funding from Otsuka, Sumitomo, and Mochida; and lecture fees from AbbVie, AstraZeneca, Asuka, Otsuka, Taisho, and Gilead Sciences. Masatoshi Kudo, MD, PhD: honoraria from Chugai, Eisai, MSD, AstraZeneca, and Takeda; and research funding from AbbVie, EA Pharma, Eisai, GE Healthcare, Gilead Sciences, Otsuka, Sumitomo Dainippon Pharma, Taiho, and Takeda.
: Study approval statement: The entire study protocol was approved by the Institutional Ethics Committee of NHO Takasaki General Medical Center (IRB No. TGMC2024-03). After receiving official approval, this study was conducted as a retrospective analysis of database records in accordance with the Guidelines for Clinical Research issued by the Ministry of Health and Welfare of Japan.Consent to participate statement: All procedures were done in accordance with the Declaration of Helsinki. Data were anonymized before analysis to protect patient privacy. Written informed consent was obtained from all patients before treatment. Informed consent for the analysis was obtained from each patient prior to Clinical Research Committee approval with an opt-out option, while written informed consent was obtained from each patient after approval.
